Clinical Trial Update: A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps. [Phase 2]

View source ↗

Summary

Phase 2 clinical study of TQH2722 Injection for chronic sinusitis with or without nasal polyps has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis
• Rhinosinusitis Without Nasal Polyps
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• TQH2722 (TQH2722)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Conditions: Sinusitis | Phase 2 | Status: COMPLETED